Pulmatrix, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2021 Annual Meeting of Stockholders held by Pulmatrix, Inc. on June 17, 2021. The company is incorporated in Delaware and its common stock trades on The NASDAQ Stock Market LLC under the symbol "PULM".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A total of 31,388,300 shares were present in person or by proxy. The following matters were voted upon:
- Election of Directors: Two Class I directors were elected to serve until the 2024 Annual Meeting.
- Todd Bazemore: 17,811,322 votes For; 0 Against; 933,563 Withheld/Abstained; 12,643,414 Broker Non-Votes.
- Christopher Cabell, M.D.: 16,146,004 votes For; 0 Against; 2,598,881 Withheld/Abstained; 12,643,414 Broker Non-Votes.
- Ratification of Auditors: The appointment of Marcum LLP as the independent registered public accounting firm for the 2021 fiscal year was ratified.
- Results: 29,996,931 votes For; 365,385 Against; 1,025,983 Withheld/Abstained; 0 Broker Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. For further details on the proposals, the filing references the definitive proxy statement filed on April 29, 2021.
Investor Verification Checklist
- Verify the final voting results for the election of Todd Bazemore and Christopher Cabell, M.D.
- Confirm the ratification of Marcum LLP as the independent auditor for the 2021 fiscal year.
- Review the definitive proxy statement filed on April 29, 2021, for detailed background on the director nominees and auditor appointment.